We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion.
- Authors
Practice Committee of the Oncofertility Consortium; Salama, Mahmoud; Laronda, Monica M.; Laura, Erin Rowell; Goldman, Kara; Smith, Kristin; Pavone, MaryEllen; Duncan, Francesca E.; Brannigan, Robert; Ataman-Millhouse, Lauren; Patrizio, Pasquale; Rodriguez-Wallberg, Kenny A.; Okutsu-Horage, Yuki; Suzuki, Nao; Lambertini, Matteo; Stern, Catharyn (Kate); Gomez-Lobo, Veronica; Maher, Jacqueline Y.; Hsieh, Michael H.; Moravek, Molly B.
- Abstract
Purpose: The main objective of Repro-Can-OPEN Study Part 2 is to learn more about oncofertility practices in optimum resource settings to provide a roadmap to establish oncofertility best practice models. Methods: As an extrapolation for oncofertility best practice models in optimum resource settings, we surveyed 25 leading and well-resourced oncofertility centers and institutions from the USA, Europe, Australia, and Japan. The survey included questions on the availability and degree of utilization of fertility preservation options in case of childhood cancer, breast cancer, and blood cancer. Results: All surveyed centers responded to all questions. Responses and their calculated oncofertility scores showed three major characteristics of oncofertility practice in optimum resource settings: (1) strong utilization of sperm freezing, egg freezing, embryo freezing, ovarian tissue freezing, gonadal shielding, and fractionation of chemo- and radiotherapy; (2) promising utilization of GnRH analogs, oophoropexy, testicular tissue freezing, and oocyte in vitro maturation (IVM); and (3) rare utilization of neoadjuvant cytoprotective pharmacotherapy, artificial ovary, in vitro spermatogenesis, and stem cell reproductive technology as they are still in preclinical or early clinical research settings. Proper technical and ethical concerns should be considered when offering advanced and experimental oncofertility options to patients. Conclusions: Our Repro-Can-OPEN Study Part 2 proposed installing specific oncofertility programs for common cancers in optimum resource settings as an extrapolation for best practice models. This will provide efficient oncofertility edification and modeling to oncofertility teams and related healthcare providers around the globe and help them offer the best care possible to their patients.
- Subjects
FERTILITY preservation; MEDICAL personnel; OVUM cryopreservation; GERM cells; CHILDHOOD cancer; REPRODUCTIVE technology; HUMAN in vitro fertilization; CYTOPROTECTION
- Publication
Journal of Assisted Reproduction & Genetics, 2021, Vol 38, Issue 1, p163
- ISSN
1058-0468
- Publication type
Article
- DOI
10.1007/s10815-020-02012-0